• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类Flt3在造血干细胞和粒细胞/巨噬细胞祖细胞阶段表达,以维持细胞存活。

Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.

作者信息

Kikushige Yoshikane, Yoshimoto Goichi, Miyamoto Toshihiro, Iino Tadafumi, Mori Yasuo, Iwasaki Hiromi, Niiro Hiroaki, Takenaka Katsuto, Nagafuji Koji, Harada Mine, Ishikawa Fumihiko, Akashi Koichi

机构信息

Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

出版信息

J Immunol. 2008 Jun 1;180(11):7358-67. doi: 10.4049/jimmunol.180.11.7358.

DOI:10.4049/jimmunol.180.11.7358
PMID:18490735
Abstract

FLT3/FLK2, a member of the receptor tyrosine kinase family, plays a critical role in maintenance of hematopoietic homeostasis, and the constitutively active form of the FLT3 mutation is one of the most common genetic abnormalities in acute myelogenous leukemia. In murine hematopoiesis, Flt3 is not expressed in self-renewing hematopoietic stem cells, but its expression is restricted to the multipotent and the lymphoid progenitor stages at which cells are incapable of self-renewal. We extensively analyzed the expression of Flt3 in human (h) hematopoiesis. Strikingly, in both the bone marrow and the cord blood, the human hematopoietic stem cell population capable of long-term reconstitution in xenogeneic hosts uniformly expressed Flt3. Furthermore, human Flt3 is expressed not only in early lymphoid progenitors, but also in progenitors continuously along the granulocyte/macrophage pathway, including the common myeloid progenitor and the granulocyte/macrophage progenitor. We further found that human Flt3 signaling prevents stem and progenitors from spontaneous apoptotic cell death at least through up-regulating Mcl-1, an indispensable survival factor for hematopoiesis. Thus, the distribution of Flt3 expression is considerably different in human and mouse hematopoiesis, and human FLT3 signaling might play an important role in cell survival, especially at stem and progenitor cells that are critical cellular targets for acute myelogenous leukemia transformation.

摘要

FLT3/FLK2是受体酪氨酸激酶家族的成员之一,在维持造血稳态中起关键作用,FLT3突变的组成型激活形式是急性髓性白血病中最常见的基因异常之一。在小鼠造血过程中,Flt3在自我更新的造血干细胞中不表达,但其表达仅限于多能和淋巴祖细胞阶段,而这些细胞无法自我更新。我们广泛分析了Flt3在人类造血过程中的表达。令人惊讶的是,在骨髓和脐血中,能够在异种宿主中长期重建的人类造血干细胞群体均一致表达Flt3。此外,人类Flt3不仅在早期淋巴祖细胞中表达,而且在沿粒细胞/巨噬细胞途径的祖细胞中持续表达,包括常见髓系祖细胞和粒细胞/巨噬细胞祖细胞。我们进一步发现,人类Flt3信号至少通过上调Mcl-1(造血过程中不可或缺的生存因子)来防止干细胞和祖细胞发生自发性凋亡细胞死亡。因此,Flt3表达的分布在人类和小鼠造血过程中有很大差异,人类FLT3信号可能在细胞存活中起重要作用,尤其是在急性髓性白血病转化的关键细胞靶点——干细胞和祖细胞中。

相似文献

1
Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.人类Flt3在造血干细胞和粒细胞/巨噬细胞祖细胞阶段表达,以维持细胞存活。
J Immunol. 2008 Jun 1;180(11):7358-67. doi: 10.4049/jimmunol.180.11.7358.
2
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.白血病细胞中FLT3受体的表达及对FLT3配体的反应。
Leukemia. 1996 Apr;10(4):588-99.
3
Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity.骨髓中Lin(-)Sca1(+)c-kit(+)干细胞区室中Flt3表达的上调伴随着自我更新能力的丧失。
Immunity. 2001 Oct;15(4):659-69. doi: 10.1016/s1074-7613(01)00220-5.
4
FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.FLT3 表达起始于完全多能的造血祖细胞。
Blood. 2011 Aug 11;118(6):1544-8. doi: 10.1182/blood-2010-10-316232. Epub 2011 May 31.
5
Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors.阈值水平的 Flt3-ligand 是淋巴祖细胞和 B 细胞前体生成和存活所必需的。
Eur J Immunol. 2011 Feb;41(2):324-34. doi: 10.1002/eji.201040710.
6
Flk2/Flt3 promotes both myeloid and lymphoid development by expanding non-self-renewing multipotent hematopoietic progenitor cells.Flk2/Flt3 通过扩增非自我更新的多能造血祖细胞促进髓系和淋系发育。
Exp Hematol. 2014 Mar;42(3):218-229.e4. doi: 10.1016/j.exphem.2013.11.013. Epub 2013 Dec 11.
7
Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to ITD mutations.胎儿和新生儿造血祖细胞在功能和转录水平上对ITD突变具有抗性。
Elife. 2016 Nov 23;5:e18882. doi: 10.7554/eLife.18882.
8
Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment.Flt3在小鼠造血干细胞区室中的选择性表达。
Int J Mol Sci. 2017 May 12;18(5):1037. doi: 10.3390/ijms18051037.
9
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.MLL-AF9与FLT3在急性髓性白血病中的协同作用:一种用于快速治疗评估模型的建立
Leukemia. 2008 Jan;22(1):66-77. doi: 10.1038/sj.leu.2404951. Epub 2007 Sep 13.
10
The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.Flt3配体可促进具有髓系及B淋巴细胞系潜能的原始造血祖细胞的存活。它能抑制细胞凋亡,并对抗肿瘤坏死因子-α和转化生长因子-β的作用。
J Immunol. 1996 Oct 1;157(7):2953-60.

引用本文的文献

1
Targeting the roots of myeloid malignancies with T cell receptors.利用T细胞受体靶向髓系恶性肿瘤的根源。
Nat Rev Cancer. 2025 Aug 21. doi: 10.1038/s41568-025-00857-0.
2
A reliable prognostic model for hepatocellular carcinoma using neutrophil extracellular traps and immune related genes.一种利用中性粒细胞胞外诱捕网和免疫相关基因构建的肝细胞癌可靠预后模型。
Sci Rep. 2025 Jun 3;15(1):19390. doi: 10.1038/s41598-025-01335-1.
3
Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions.抗髓系白血病细胞的单克隆抗体:当前认知与未来方向。
Int J Mol Sci. 2025 May 10;26(10):4571. doi: 10.3390/ijms26104571.
4
Development of multivalent CAR T cells as dual immunotherapy and conditioning agents.多价嵌合抗原受体T细胞作为双重免疫疗法和预处理剂的开发。
Mol Ther Oncol. 2025 Jan 30;33(1):200944. doi: 10.1016/j.omton.2025.200944. eCollection 2025 Mar 20.
5
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.造血系统恶性肿瘤亚克隆发生和依赖性的体内模型。
Cancer Cell. 2024 Nov 11;42(11):1955-1969.e7. doi: 10.1016/j.ccell.2024.10.009.
6
Protective effect of ginseng extract and total ginsenosides on hematopoietic stem cell damage by inhibiting cell apoptosis and regulating the intestinal microflora.人参提取物及总皂苷通过抑制细胞凋亡和调节肠道菌群对造血干细胞损伤的保护作用。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5455. Epub 2024 Nov 8.
7
T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting.血液系统恶性肿瘤中的 T 细胞重定向疗法:为改善靶向性而开发的新策略和新进展。
Mol Ther. 2024 Sep 4;32(9):2856-2891. doi: 10.1016/j.ymthe.2024.07.028. Epub 2024 Aug 5.
8
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.工程诱导性白血病相关融合蛋白可实现大规模体外生产功能性人吞噬细胞。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2312499121. doi: 10.1073/pnas.2312499121. Epub 2024 Jun 10.
9
Current knowledge about FLT3 gene mutations, exploring the isoforms, and protein importance in AML.关于 FLT3 基因突变、异构体探索以及在 AML 中蛋白质重要性的现有知识。
Mol Biol Rep. 2024 Apr 16;51(1):521. doi: 10.1007/s11033-024-09452-2.
10
Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model.髓系和树突状细胞增强了人源化 BRGSF-HIS 临床前模型中治疗诱导的细胞因子释放综合征特征。
Front Immunol. 2024 Feb 7;15:1357716. doi: 10.3389/fimmu.2024.1357716. eCollection 2024.